Share This Link

Decreased bladder capacity: Aging is associated with a gradual reduction in bladder capacity because the bladder becomes less elastic and less able to distend as it fills with urine. This change contributes primarily to urinary frequency, urgency, and nocturia rather than being the principal cause of urinary incontinence. Although decreased bladder capacity may worsen symptoms, the loss of bladder support and muscle tone is more directly responsible for involuntary urine leakage.

Increase in nephrons: The number of functional nephrons decreases rather than increases with advancing age. Progressive nephron loss contributes to a decline in glomerular filtration rate (GFR), reduced renal reserve, and diminished ability to concentrate urine. An increase in nephron number does not occur as part of normal aging and therefore does not contribute to urinary incontinence.

Enhanced kidney filtration: Renal filtration does not become enhanced with aging; instead, glomerular filtration rate gradually declines because of reduced renal blood flow, nephron loss, and structural changes within the kidneys. This reduction affects the kidneys' ability to regulate fluid and electrolyte balance but is not the primary mechanism responsible for urinary incontinence. Lower urinary tract changes, particularly loss of bladder and sphincter tone, play the predominant role in the development of age-related urinary incontinence.

Obtain a TSH level to confirm diagnosis before initiating treatment: Although thyroid function tests such as TSH, free T4, and T3 help confirm hyperthyroidism, treatment of thyroid storm should never be delayed while awaiting laboratory confirmation. Thyroid storm is primarily a clinical diagnosis based on signs such as hyperthermia, severe tachycardia, altered mental status, and cardiovascular instability. Immediate intervention is essential because delayed treatment significantly increases the risk of heart failure, dysrhythmias, multiple organ dysfunction, and death.

Provide patient education on stress management techniques to prevent worsening of symptoms: Stress management is an important component of long-term management for clients with hyperthyroidism because physical and emotional stress can precipitate exacerbations of the disease. However, during an acute thyroid storm, the client's condition is unstable and requires emergency medical treatment rather than health education. Patient teaching should be deferred until the client has been stabilized.

Administer a prescribed antithyroid agent to inhibit thyroid hormone synthesis: Antithyroid medications such as methimazole or propylthiouracil (PTU) are essential components of thyroid storm treatment because they inhibit the synthesis of new thyroid hormones, and PTU also decreases peripheral conversion of T4 to the more active T3. However, these medications require several hours before producing a significant clinical effect and therefore do not immediately reverse the severe cardiovascular manifestations.

Assess the patient's current cardiovascular status: Assessment of cardiovascular status is important because severe hyperglycemia may lead to dehydration, tachycardia, hypotension, and impaired tissue perfusion secondary to osmotic diuresis. However, unless the client demonstrates signs of cardiovascular instability, this assessment does not directly correct the elevated blood glucose level. After the initial assessment confirms that the client is stable, the priority is to implement the prescribed treatment to reduce hyperglycemia.

Encourage the patient to drink a high-sugar beverage: Administering a high-sugar beverage is appropriate for the treatment of hypoglycemia, not hyperglycemia. Providing additional glucose to a patient with already elevated blood glucose levels would further increase plasma glucose concentrations, exacerbate osmotic diuresis, worsen dehydration, and increase the risk of complications such as diabetic ketoacidosis or hyperosmolar hyperglycemic state.

Notify the healthcare provider about the elevated blood glucose levels: The healthcare provider should be informed if the client's hyperglycemia is severe, persistent, or accompanied by evidence of diabetic ketoacidosis, hyperosmolar hyperglycemic state, or other clinical deterioration. However, if a prescribed insulin regimen or sliding-scale insulin order is already available, the nurse should implement the treatment without unnecessary delay. Timely administration of prescribed therapy is a higher priority.

The client has gained 0.91 kg (2 lb) in 24 hr.: A weight gain of 0.91 kg (2 lb) in 24 hours suggests continued water retention rather than successful treatment of SIADH. Excess ADH causes the kidneys to retain free water, leading to dilutional hyponatremia and increased body weight. Since tolvaptan promotes free-water excretion, an expected therapeutic response would be stabilization or reduction in body weight rather than additional weight gain.

The client is reporting weakness: Weakness is not an expected therapeutic outcome because it may indicate persistent hyponatremia, electrolyte imbalance, dehydration, or overly rapid correction of serum sodium levels. Neuromuscular symptoms such as weakness, fatigue, muscle cramps, confusion, or lethargy warrant further assessment since they may signal inadequate treatment response or complications.

The client's serum sodium is 128 mg/dL (136 to 145 mEq/L): A serum sodium level of 128 mEq/L remains below the normal reference range of 136–145 mEq/L, indicating persistent hyponatremia despite treatment. The primary goal of tolvaptan therapy is to increase serum sodium by promoting free-water excretion and correcting dilutional hyponatremia. Continued low sodium levels suggest that the desired therapeutic effect has not yet been achieved and require ongoing monitoring and possible adjustment of treatment.

Increase the patient's fluid intake to promote hydration and maintain electrolyte balance: Encouraging fluid intake is beneficial because clients with Addison's disease are prone to dehydration and hypovolemia due to aldosterone deficiency, which causes excessive renal sodium and water loss. Adequate hydration helps support intravascular volume and tissue perfusion; however, increasing oral fluids alone does not correct the underlying cortisol deficiency responsible for the patient's symptoms.

Encourage the patient to perform light exercises to stimulate energy levels: Light physical activity may improve muscle strength and overall well-being in patients whose adrenal insufficiency is well controlled. However, during periods of increased fatigue and gastrointestinal symptoms, exercise may increase metabolic demands, worsen exhaustion, and potentially precipitate adrenal crisis if cortisol levels remain inadequate. Stabilization with appropriate corticosteroid therapy should occur before encouraging increased physical activity.

Provide the patient with a high sugar diet to boost energy levels: Although hypoglycemia can occur in Addison's disease because cortisol is essential for normal gluconeogenesis, routinely providing a high-sugar diet is not the appropriate treatment for persistent fatigue. Excessive sugar intake does not replace deficient cortisol or correct the underlying endocrine disorder and may contribute to undesirable fluctuations in blood glucose levels.

Reducing episodes of incontinence: Reducing incontinent episodes is an important outcome of bladder training because it improves skin integrity, decreases the risk of urinary tract infections, and enhances the patient's quality of life. However, this is a broad outcome that is achieved by first enabling the patient to recognize the need to void and reach the toilet successfully. Although desirable, it is not the primary nursing goal during bladder training.

Assisting with catheterization daily: Routine catheterization is not a treatment for functional urinary incontinence because the patient's bladder function is generally intact. Indwelling or intermittent catheterization unnecessarily increases the risk of catheter-associated urinary tract infections (CAUTIs), urethral trauma, and reduced bladder function unless there is a specific medical indication such as urinary retention. Behavioral interventions and scheduled toileting are preferred over catheterization.

Improving bladder muscle strength: Improving bladder muscle strength is more appropriate for patients with stress urinary incontinence, in whom pelvic floor muscle weakness contributes to urine leakage. These patients often benefit from pelvic floor (Kegel) exercises to strengthen the pelvic musculature and improve urethral support. Functional incontinence, however, results from impaired mobility or cognitive barriers rather than weakened bladder muscles.

Assess for signs of infection: Clients with nephrotic syndrome are at increased risk of infection because urinary loss of immunoglobulins impairs the body's immune defenses. Assessing for fever, localized redness, elevated white blood cell count, or other signs of infection is an important component of ongoing nursing care. However, sudden weight gain primarily indicates significant fluid retention rather than infection, making interventions directed at reducing excess fluid a higher priority.

Encourage walking and exercise: Ambulation and light exercise may improve circulation, reduce the risk of venous thromboembolism, and help maintain muscle strength in clients with nephrotic syndrome. However, exercise does not rapidly remove excess fluid or correct the underlying pathophysiology responsible for sudden weight gain. The priority is to address fluid overload before encouraging increased physical activity.

Increase fluid intake: Increasing fluid intake is inappropriate because clients with nephrotic syndrome who experience rapid weight gain are already retaining excessive fluid. Additional fluid intake may worsen edema, increase intravascular volume, exacerbate hypertension, and increase the risk of pulmonary edema or heart failure. Fluid intake should be managed according to the healthcare provider's prescription and the client's overall fluid and electrolyte status rather than increased routinely.

Serum phosphate levels: Serum phosphate is not routinely affected by diabetes insipidus or by desmopressin therapy and therefore is not a priority laboratory value for ongoing monitoring. Abnormal phosphate levels are more commonly associated with disorders such as chronic kidney disease, hyperparathyroidism, tumor lysis syndrome, or vitamin D abnormalities. Phosphate does not provide the most clinically relevant information regarding the effectiveness or safety of desmopressin treatment.

Serum calcium levels: Serum calcium is not directly influenced by the pathophysiology of diabetes insipidus or the pharmacological action of desmopressin. Calcium homeostasis is primarily regulated by parathyroid hormone, calcitonin, and vitamin D rather than antidiuretic hormone. Although calcium abnormalities should be addressed if present, routine calcium monitoring is not the priority when evaluating the therapeutic response or adverse effects of desmopressin.

Blood urea nitrogen (BUN): Blood urea nitrogen is an indicator of renal function, hydration status, and protein metabolism and may initially be elevated in untreated diabetes insipidus due to dehydration and reduced renal perfusion. However, BUN is an indirect marker and changes more slowly than serum sodium during treatment with desmopressin. While monitoring renal function remains important, serum sodium provides a more immediate and sensitive assessment of complications associated with desmopressin therapy.